Panama Relocates 100 Hemodialysis Patients to Remodeled Hospital Room
Translated from Spanish, summarized and contextualized by DistantNews.
At a glance
- Approximately 100 hemodialysis patients have been transferred to a newly remodeled room at Santo Tomás Hospital.
- The move is part of the Social Security Fund's (CSS) plan to improve and expand its dialysis services.
- Panama currently has 2,857 patients with chronic kidney disease requiring renal replacement therapy.
The Panamanian Social Security Fund (CSS) has relocated about 100 hemodialysis patients to a newly remodeled facility at Santo Tomás Hospital. These patients previously received treatment at the Arnulfo Arias Madrid Hospital Complex. The move began on Monday, August 3.
Dr. Karla Rodríguez, deputy national coordinator for Renal Replacement Therapies and Chronic Kidney Disease at the CSS, explained that the remodeling of the Metro 3 room is part of an institutional strategy to strengthen the healthcare network and increase coverage for patients needing dialysis. "This measure strengthens our care capacity and guarantees timely and quality service," Rodríguez stated.
The relocated patients were selected by the Social Work team and will attend treatment in two shifts, starting at 6:00 a.m. and 11:00 a.m. The CSS also announced that new dialysis units are pending delivery, which will further optimize services and boost the national network's capacity.
Currently, Panama registers 2,857 patients with chronic kidney disease undergoing renal replacement therapy. Of these, 2,366 are on hemodialysis and 491 are on peritoneal dialysis. The number of patients receiving hemodialysis has increased by 3.9% compared to 2024, adding 89 individuals. Until July 2026, the Arnulfo Arias Madrid Hospital Complex had the largest patient load with 368 individuals.
This measure strengthens our care capacity and guarantees timely and quality service.
Originally published by TVN Panamá in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.